Related Experiment Video
Updated: Mar 27, 2026
06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
3.1K
Cell-Capture and Release Platform Based on Peptide-Aptamer-Modified Nanowires.
Jingying Li1, Cui Qi1, Zheng Lian1
1CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology , Beijing 100190, China.
ACS Applied Materials & Interfaces
|January 9, 2016
Summary
Researchers developed a novel nanowire platform for specific cancer cell capture and release. This reusable system enhances cell separation and diagnosis, offering new bioapplication opportunities.
Area of Science:
- Biotechnology
- Materials Science
- Nanotechnology
Background:
- Nanowires show promise for bioapplications like drug delivery and sensing.
- Existing cell capture methods may lack specificity or reusability.
Purpose of the Study:
- To develop a unique cell-capture and release platform utilizing nanowires.
- To achieve specific and efficient capture of cancer cells.
- To enable reversible binding for downstream analysis and substrate reuse.
Main Methods:
- Fabrication of a nanowire-based platform.
- Functionalization with surface-binding peptides and cell-targeting aptamers.
- Testing for specific cancer cell capture and evaluating binding reversibility.
Main Results:
- Demonstrated specific and efficient capture of cancer cells using the nanowire platform.
- Confirmed the reversibility of the cell binding process.
- Showcased the potential for substrate reusability.
Conclusions:
- The developed nanowire platform offers a novel approach for cell capture and release.
- This technology facilitates specific cancer cell separation and diagnosis.
- The reversible binding mechanism opens new avenues for cell-based assays and systems.
